PINK1/Parkin-mediated mitophagy in neurodegenerative diseases

J Li, D Yang, Z Li, M Zhao, D Wang, Z Sun, P Wen… - Ageing research …, 2023 - Elsevier
Mitochondria play key roles in bioenergetics, metabolism, and signaling; therefore, stable
mitochondrial function is essential for cell survival, particularly in energy-intensive neuronal …

The pathogenesis of Parkinson's disease

HR Morris, MG Spillantini, CM Sue, CH Williams-Gray - The Lancet, 2024 - thelancet.com
Parkinson's disease is a progressive neurodegenerative condition associated with the
deposition of aggregated α-synuclein. Insights into the pathogenesis of Parkinson's disease …

Discovery of XL01126: a potent, fast, cooperative, selective, orally bioavailable, and blood–brain barrier penetrant PROTAC degrader of leucine-rich repeat kinase 2

X Liu, AF Kalogeropulou, S Domingos… - Journal of the …, 2022 - ACS Publications
Leucine-rich repeat kinase 2 (LRRK2) is one of the most promising targets for Parkinson's
disease. LRRK2-targeting strategies have primarily focused on type 1 kinase inhibitors …

BNIP3L/NIX regulates both mitophagy and pexophagy

LP Wilhelm, J Zapata‐Muñoz, B Villarejo‐Zori… - The EMBO …, 2022 - embopress.org
Mitochondria and peroxisomes are closely related metabolic organelles, both in terms of
origin and in terms of function. Mitochondria and peroxisomes can also be turned over by …

Oxidative stress, mitochondrial dysfunction, and neuroprotection of polyphenols with respect to resveratrol in Parkinson's disease

HC Kung, KJ Lin, CT Kung, TK Lin - Biomedicines, 2021 - mdpi.com
Parkinson's disease (PD) is the second most common neurodegenerative disease and is
characterized by dopaminergic neuronal loss. The exact pathogenesis of PD is complex and …

Pharmacological rescue of impaired mitophagy in Parkinson's disease-related LRRK2 G2019S knock-in mice

F Singh, AR Prescott, P Rosewell, G Ball, AD Reith… - elife, 2021 - elifesciences.org
Parkinson's disease (PD) is a major and progressive neurodegenerative disorder, yet the
biological mechanisms involved in its aetiology are poorly understood. Evidence links this …

NADPH and mitochondrial quality control as targets for a circadian-based fasting and exercise therapy for the treatment of Parkinson's disease

WM Curtis, WA Seeds, MP Mattson, PC Bradshaw - Cells, 2022 - mdpi.com
Dysfunctional mitochondrial quality control (MQC) is implicated in the pathogenesis of
Parkinson's disease (PD). The improper selection of mitochondria for mitophagy increases …

The NRF2-dependent transcriptional regulation of antioxidant defense pathways: Relevance for cell type-specific vulnerability to neurodegeneration and therapeutic …

SM Boas, KL Joyce, RM Cowell - Antioxidants, 2021 - mdpi.com
Oxidative stress has been implicated in the etiology and pathobiology of various
neurodegenerative diseases. At baseline, the cells of the nervous system have the capability …

Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson's disease models

MG Williamson, M Madureira… - Human Molecular …, 2023 - academic.oup.com
Abstract Mutations in the Leucine-Rich Repeat Kinase 2 (LRRK2) gene have been identified
as one of the most common genetic causes of Parkinson's disease (PD). The LRRK2 PD …

DGAT1 activity synchronises with mitophagy to protect cells from metabolic rewiring by iron depletion

M Long, A Sanchez‐Martinez, M Longo, F Suomi… - The EMBO …, 2022 - embopress.org
Mitophagy removes defective mitochondria via lysosomal elimination. Increased mitophagy
coincides with metabolic reprogramming, yet it remains unknown whether mitophagy is a …